Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Caryn S. Ross-Innes(Cancer Research UK), Rory Stark(Cancer Research UK), Andrew E. Teschendorff(University College London), Kelly A. Holmes(Cancer Research UK), H. Raza Ali(Cambridge University Hospitals NHS Foundation Trust), Mark Dunning(Cancer Research UK), Gordon D. Brown(Cancer Research UK), Ondřej Gojiš(Hammersmith Hospital), Ian O. Ellis(Nottingham University Hospitals NHS Trust), Andrew R. Green(Nottingham University Hospitals NHS Trust), Simak Ali(Imperial College London), Suet‐Feung Chin(Cancer Research UK), Carlo Palmieri(Imperial College London), Carlos Caldas(University of Cambridge), Jason S. Carroll(Cancer Research UK)
Cited by 2,356
Abstract
Related Papers
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
|The Lancet|2005|7.6k
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
Christos Sotiriou, Pratyaksha Wirapati, Sherene Loi et al.|JNCI Journal of the National Cancer Institute|2006|2.1k